220 related articles for article (PubMed ID: 21507633)
61. Structure-based design of low-nanomolar PIM kinase inhibitors.
Ishchenko A; Zhang L; Le Brazidec JY; Fan J; Chong JH; Hingway A; Raditsis A; Singh L; Elenbaas B; Hong VS; Marcotte D; Silvian L; Enyedy I; Chao J
Bioorg Med Chem Lett; 2015 Feb; 25(3):474-80. PubMed ID: 25575657
[TBL] [Abstract][Full Text] [Related]
62. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Hebeisen P; Haap W; Kuhn B; Mohr P; Wessel HP; Zutter U; Kirchner S; Ruf A; Benz J; Joseph C; Alvarez-Sánchez R; Gubler M; Schott B; Benardeau A; Tozzo E; Kitas E
Bioorg Med Chem Lett; 2011 Jun; 21(11):3237-42. PubMed ID: 21550236
[TBL] [Abstract][Full Text] [Related]
63. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Lira R; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Vetelino BC; Xie L; Zhang L; Pustilnik LR; Wood KM; O'Donnell CJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2906-11. PubMed ID: 22429469
[TBL] [Abstract][Full Text] [Related]
64. Fragment-hopping-based discovery of a novel chemical series of proto-oncogene PIM-1 kinase inhibitors.
Saluste G; Albarran MI; Alvarez RM; Rabal O; Ortega MA; Blanco C; Kurz G; Salgado A; Pevarello P; Bischoff JR; Pastor J; Oyarzabal J
PLoS One; 2012; 7(10):e45964. PubMed ID: 23115625
[TBL] [Abstract][Full Text] [Related]
65. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
Barf T; Lehmann F; Hammer K; Haile S; Axen E; Medina C; Uppenberg J; Svensson S; Rondahl L; Lundbäck T
Bioorg Med Chem Lett; 2009 Mar; 19(6):1745-8. PubMed ID: 19217286
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
[TBL] [Abstract][Full Text] [Related]
67. Structure-based design of thienobenzoxepin inhibitors of PI3-kinase.
Staben ST; Siu M; Goldsmith R; Olivero AG; Do S; Burdick DJ; Heffron TP; Dotson J; Sutherlin DP; Zhu BY; Tsui V; Le H; Lee L; Lesnick J; Lewis C; Murray JM; Nonomiya J; Pang J; Prior WW; Salphati L; Rouge L; Sampath D; Sideris S; Wiesmann C; Wu P
Bioorg Med Chem Lett; 2011 Jul; 21(13):4054-8. PubMed ID: 21636270
[TBL] [Abstract][Full Text] [Related]
68. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
69. Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5.
Granchi C; Roy S; Mottinelli M; Nardini E; Campinoti F; Tuccinardi T; Lanza M; Betti L; Giannaccini G; Lucacchini A; Martinelli A; Macchia M; Minutolo F
Bioorg Med Chem Lett; 2011 Dec; 21(24):7331-6. PubMed ID: 22056743
[TBL] [Abstract][Full Text] [Related]
70. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
[TBL] [Abstract][Full Text] [Related]
71. Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors.
Suchaud V; Gavara L; Saugues E; Nauton L; Théry V; Anizon F; Moreau P
Bioorg Med Chem; 2013 Jul; 21(14):4102-11. PubMed ID: 23735828
[TBL] [Abstract][Full Text] [Related]
72. Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.
Barawkar DA; Bandyopadhyay A; Deshpande A; Koul S; Kandalkar S; Patil P; Khose G; Vyas S; Mone M; Bhosale S; Singh U; De S; Meru A; Gundu J; Chugh A; Palle VP; Mookhtiar KA; Vacca JP; Chakravarty PK; Nargund RP; Wright SD; Roy S; Graziano MP; Cully D; Cai TQ; Singh SB
Bioorg Med Chem Lett; 2012 Jul; 22(13):4341-7. PubMed ID: 22658862
[TBL] [Abstract][Full Text] [Related]
73. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
[TBL] [Abstract][Full Text] [Related]
74. In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.
Li J; Bronk BS; Dirlam JP; Blize AE; Bertinato P; Jaynes BH; Hickman A; Miskell C; Pillai UA; Tibbitts JS; Haven ML; Kolosko NL; Barry CJ; Manion TB
Bioorg Med Chem Lett; 2007 Apr; 17(7):1996-9. PubMed ID: 17276061
[TBL] [Abstract][Full Text] [Related]
75. Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.
Kato Y; Hin N; Maita N; Thomas AG; Kurosawa S; Rojas C; Yorita K; Slusher BS; Fukui K; Tsukamoto T
Eur J Med Chem; 2018 Nov; 159():23-34. PubMed ID: 30265959
[TBL] [Abstract][Full Text] [Related]
76. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
77. Thiirancarboxamides as inhibitors of papain.
Bruno G; Schirmeister T
Arch Pharm (Weinheim); 2004 Feb; 337(2):90-5. PubMed ID: 14981665
[TBL] [Abstract][Full Text] [Related]
78. Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold.
Nishiguchi GA; Burger MT; Han W; Lan J; Atallah G; Tamez V; Lindvall M; Bellamacina C; Garcia P; Feucht P; Zavorotinskaya T; Dai Y; Wong K
Bioorg Med Chem Lett; 2016 May; 26(9):2328-32. PubMed ID: 26995528
[TBL] [Abstract][Full Text] [Related]
79. Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR).
Tsou HR; MacEwan G; Birnberg G; Grosu G; Bursavich MG; Bard J; Brooijmans N; Toral-Barza L; Hollander I; Mansour TS; Ayral-Kaloustian S; Yu K
Bioorg Med Chem Lett; 2010 Apr; 20(7):2321-5. PubMed ID: 20188552
[TBL] [Abstract][Full Text] [Related]
80. Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors.
Wu B; Wang HL; Cee VJ; Lanman BA; Nixey T; Pettus L; Reed AB; Wurz RP; Guerrero N; Sastri C; Winston J; Lipford JR; Lee MR; Mohr C; Andrews KL; Tasker AS
Bioorg Med Chem Lett; 2015 Feb; 25(4):775-80. PubMed ID: 25616902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
